105 related articles for article (PubMed ID: 9884347)
1. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.
Dal Canto RA; Shaw MK; Nolan GP; Steinman L; Fathman CG
Clin Immunol; 1999 Jan; 90(1):10-4. PubMed ID: 9884347
[TBL] [Abstract][Full Text] [Related]
2. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.
Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG
Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
Selmaj K; Raine CS; Cross AH
Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
[TBL] [Abstract][Full Text] [Related]
4. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
5. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
6. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
[TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
8. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
9. A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP.
Xu B; Scott DW
Clin Immunol; 2004 Apr; 111(1):47-52. PubMed ID: 15093551
[TBL] [Abstract][Full Text] [Related]
10. Fulminant experimental autoimmune encephalo-myelitis induced by retrovirally mediated TCR gene transfer.
Stolzer AL; Sadelain M; Sant'Angelo DB
Eur J Immunol; 2005 Jun; 35(6):1822-30. PubMed ID: 15909313
[TBL] [Abstract][Full Text] [Related]
11. Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis.
Louie KA; Weiner LP; Du J; Kochounian HH; Fling SP; Wei W; McMillan M
Gene Ther; 2005 Jul; 12(14):1145-53. PubMed ID: 15772685
[TBL] [Abstract][Full Text] [Related]
12. Estrogen inhibits systemic T cell expression of TNF-alpha and recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice developing experimental encephalomyelitis.
Ito A; Buenafe AC; Matejuk A; Zamora A; Silverman M; Dwyer J; Vandenbark AA; Offner H
Clin Immunol; 2002 Mar; 102(3):275-82. PubMed ID: 11890714
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
[TBL] [Abstract][Full Text] [Related]
14. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen.
Brocke S; Gaur A; Piercy C; Gautam A; Gijbels K; Fathman CG; Steinman L
Nature; 1993 Oct; 365(6447):642-4. PubMed ID: 7692305
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
16. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
[TBL] [Abstract][Full Text] [Related]
17. Estrogen inhibition of EAE involves effects on dendritic cell function.
Liu HY; Buenafe AC; Matejuk A; Ito A; Zamora A; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2002 Oct; 70(2):238-48. PubMed ID: 12271473
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
Kruglov AA; Lampropoulou V; Fillatreau S; Nedospasov SA
J Immunol; 2011 Dec; 187(11):5660-70. PubMed ID: 22058414
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor-2 alpha in the central nervous system of SJL mice with experimental allergic encephalomyelitis.
Chakrabarty A; Danley MM; LeVine SM
J Neurosci Res; 2004 Jun; 76(6):822-33. PubMed ID: 15160394
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
